Introduction
Congenital heart disease (CHD) remains one of the major dilemmas in pediatric cardiology and genetics. CHD affects about 1% of all live births worldwide, is complex, and may consist of heart variations that are present at birth. Although much has been learned through medical and technological advances, the basic reasons for CHD are not fully known. However, an increasing amount of evidence indicates that genetic predispositions, along with environmental factors, are essential in these cardiovascular malformations. Recent findings from studies investigating the genetic and environmental bases of CHD are reviewed in this article to provide insights into the interaction between these factors.
Genetic Factors in CHD
Some previous investigations have highlighted the role of genetic mutations leading to CHD. The genetic diagnostic method of whole-exome sequencing announced a series of candidate genes that possibly contain damaging variants in patients with certain CHD subphenotypes, including TGA. For instance, the fact that CHD patients also have an overrepresentation of genes associated with ciliary structure and movement implicates ciliary functionality in cardiac morphogenesis. Some of the genes that have been suggested include FOXH1 and DYNC2LI1 Cher and Pandey (2016), implying the fact that CHD has a polygenic nature.
Ciliary genes have such functions as the regulation of cilia, small hair-like structures that have significant roles in cell signaling and motility and are very essential in the development of hearts. The present findings of rare variants in these genes in CHD patients also substantiate their roles in the disease. For instance, Tao et al. Have described the genomic rearrangements in the DYNC2LI1 gene, which was implicated in ciliary function, in TGA, so it appears that the ciliary pathways may be involved in the development of CHD.
CHD is genetically heterogeneous; thus, it is characterized by mutations in different molecules that take part in the process of cardiac development. Research also indicated that identical pathological mutations may lead to different phenotypes of CHD as epistasis, and the genetic makeup of patients plays a major role in the outcome of the disorder. This heterogeneity complicates defining the causal mutations and analyzing the entire CHD-associated genetic network, which requires the implementation of multifaceted and integrative approaches.
Currently, genomic technologies such as next-generation sequencing have supported the steps made toward the identification of the genetic roots of CHD. The written work has created these new generation technologies through which sporadic CHD cases can be analyzed as they occur more frequently than familial CHD cases. Large-scale sequencing and analysis of large populations, and with the help of sophisticated bioinformatics tools, researchers have successfully pointed out numerous gene variants associated with CHD, thus giving further understanding of CHD genetics.